Anti-<i>Trypanosoma cruzi</i> Activity of Metabolism Modifier Compounds
Chagas disease is caused by the protozoan parasite <i>Trypanosoma cruzi</i> and affects over 6 million people worldwide. Development of new drugs to treat this disease remains a priority since those currently available have variable efficacy and frequent adverse effects, especially durin...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/2/688 |